|
| |
|
Research Support Services |
Apply for
Services |
What to Expect When Your Participate
What is Informed Consent? |
Current
Clinical Trials |
Faculty & Staff |
|
The Clinical Research Unit (CRU) at the
Department of Pediatrics research facility in E. V. Williams Hall offers children and their families within the Hampton Roads
community the opportunity to participate in national clinical trials for new and
improved pharmaceuticals. The unit offers research support services to
faculty within the Department of Pediatrics and other
departments
throughout Eastern Virginia Medical School. See list of Clinical Research Unit
faculty and staff below.
|
|
The Clinical Research Unit provides assistance to
investigators of all research experience levels for all research support needs,
whether your study is investigator-originated, part of a national protocol or an
industry-sponsored research project. Our research staff is expert in Good
Clinical Practices, and has experience in conducting industry-sponsored Phase I,
II, III, and IV clinical trials. Our 15-year history includes conducting trials
evaluating vaccines and infant formulas as well as assisting with projects in
pediatric sub-specialties including allergy, neonatology, nephrology,
otolaryngology, endocrinology, gastroenterology, genetics, infectious diseases,
and sickle cell disease. Our experience extends to assisting principle
investigators with their grants from National Institutes of Health, Centers for
Disease Control, and other federal and private funders, with a full scope of
services from research design and measurement, to grant application, research
assistance and manuscript editing. We also assist residents in their research
projects and are often successful in helping them find funding for their
projects as well.
Investigators within the Department of Pediatrics may
request full study support, consisting of budget and contract negotiation,
completion of regulatory documents, and full coordinator support.
Alternatively, the CRU has a service menu and fee schedule covering many support
services on an as needed basis. In addition, an MPH-trained
epidemiologist provides study design, database development, data management,
statistical analysis, and manuscript assistance. Coordinator orientation and
ongoing educational consultation is available to assist the investigator’s
clinic staff who are new to research and are assuming some coordinator
responsibilities.
The Clinical Research Unit provides assistance to faculty, house staff, and
other staff members from the inception of the research question through data
collection, analysis, and manuscript submission.
|
Click on the link below to access the Research Support Services
Application Form and Price List
for Available Services. For best results, we encourage
investigators to contact
Research Support Services prior to beginning a project
regardless of the level of services you may anticipate requesting.
|
|
WHAT TO EXPECT WHEN YOU
PARTICIPATE
Children receive attentive, expert care from outstanding
medical practitioners when parents enroll them in clinical studies offered by
the Clinical Trials Unit of Eastern Virginia Medical School’s Department
of Pediatrics Clinical Research Unit. Parents feel good about their participation because their
support allows doctors to gain important information to better protect all
children from disease. We also offer adult studies, providing the same caring
attention to subjects of any age.
Each clinical trial is different, but in all cases the
health of the patient is of the utmost importance. Clinical research experts
carefully analyze information collected about study subjects. The results
enable investigators, drug and medical equipment manufacturers to produce the
most effective medicine and treatments for childhood and adult illnesses. Some
results help doctors actually prevent diseases.
Study subjects receive investigational treatments and
medical care under close supervision by physicians and other research
professionals. Industry-sponsored trials have been developed by respected
pharmaceutical and biotechnology companies, and are reviewed by the US Food and
Drug Administration.
When volunteers participate in a study, their health is
carefully monitored throughout the trial. It is important that subjects and
pediatric subjects’ parents follow all instructions from the study staff, take
all prescribed medicines, keep all scheduled appointments, and report any
symptoms the subject may experience no matter how small they may seem. Subject
safety is our top priority. So is privacy. Medical records always remain
confidential and trial results provided to the pharmaceutical company never
include names of subjects or their families.
Data Collected Contributes to Medical
Knowledge
After each study, information from all subjects is analyzed
to determine if the investigational treatment is working. Results are also
analyzed to verify that the treatment is safe and to note any side effects. The
FDA closely reviews these results before approving any new drug for general
public distribution.
Even after approval, companies continue to study drugs and
compare them to other treatments for effectiveness and safety. Involvement as a
study volunteer is extremely important in bringing this knowledge to the medical
community and the benefits to people worldwide.
Supported by Trusted Experts
Staff and faculty from Eastern Virginia Medical School are
closely involved in our research. So are pediatricians at Children’s Hospital
of The King’s Daughters and from around the region. Over seventy local
pediatricians participate in our pediatric trials. These doctors appreciate the
value of clinical studies and know how important the results are for all
children.
The Clinical Research Unit conducts from 20 to 25 clinical
trials at any time. Children of all ages can participate, and several adult
studies are available. Whether you participate in one or several of our trials,
we thank you for your involvement.
|
|
When individuals, or the parents of children, agree to
participate in a clinical trial, they must sign a document giving consent to
their participation. Consent is not just a signed document; it is a process.
Study coordinators and study subjects should take time to sit down and discuss
issues related to study subject participation in a clinical research trial. To
be better prepared for this step in participation in a clinical trial, a
potential study subject should understand requirements of the process.
Requirements for informed consent include that those
involved in research (study subjects, or parents of children who will become
study subjects) must have sufficient time to consider participation. No
improper enticements or coercion (for example, excessively large payments) may
be used. The informed consent document must be in lay language with medical
terminology explained in lay terms.
When you review a consent document, look for the following
information:
-
That the study is research oriented
-
Any potential risks
-
Any potential benefits
-
Alternative treatments
-
Extent of confidentiality (sponsor and FDA may inspect
records)
-
Compensation for injury; medical treatments for
adverse effects and sources for additional information
-
Contact for further information about the study or for
information regarding injury
-
That the study subject’s participation is voluntary
and that the study subject may discontinue without prejudice.
Other information that must be included, if applicable to
the study protocol:
-
Potential for unforeseeable risk to subject, embryo,
or fetus
-
Circumstances under which subject may be terminated
from study without subject’s consent
-
Additional costs to subject related to participation
-
Consequences of study subject’s withdrawal from the
study
-
Provision for release of new information that may
affect study subject’s decision to remain in the study
-
Approximate number of study subjects to be included in
the study
If you have any questions, your study coordinator or
physician should be able to answer them to your satisfaction before you sign
your consent to the study.
|
|
E.V.M.S. Department of
Pediatrics – Clinical Research Unit
855
West Brambleton Avenue
Norfolk, Virginia 23510
(757)
688-6414
Clinical
Studies
June 2007
You are invited to enroll your child in any of the
following research studies at no cost to you. If you are interested in finding
out more about clinical trials research, or any of these studies, or if you
would like to enroll your child, contact the study coordinator listed.
Description |
Principal
Investigator |
Study
Coordinator |
|
ANTIBIOTIC STUDIES
|
|
|
-
Long-term
observational study using investigational antibiotics to treat
infectious diseases for
children and
teens 2 months to 16 years of age.
Enrollment is closed, follow-up continues.
|
David O. Matson, MD,
PhD |
Lorrie Coggsdale, RN
668-8221 |
ASTHMA STUDIES
|
|
|
-
EXCELS
study for
patients over 12 years of age, evaluating the use and side effects
of XolairÔ
compared to other asthma medications. Enrollment is closed; follow
up visits continue.
|
Cynthia Kelly, MD |
Rebecca Sheeran, RN,
MSN, CPNP
668-9563 |
-
Inflammatory
Cells.
Study of
inflammatory cell types in
children 12-18
years of age
with moderate to severe asthma.
|
Maripaz Morales, MD |
Rebecca Sheeran, RN,
MSN, CPNP
668-9563 |
|
|
|
|
|
|
|
|
|
|
|
VACCINE STUDIES
|
|
|
-
Hib and
meningococcal vaccine study
in children 2 months of age. Enrollment is closed, follow-up
continues.
|
David Matson, MD,
PhD |
Mary
Beth Donner, RN, CCRC
668-6419 |
-
Meningococcal
vaccine study
to evaluate giving study vaccine with other routine immunizations in
children 9 months of age. The vaccine is licensed for use in
children 11 years and older
|
Laura Sass, MD |
Melody Skinner, RN,
MSN, CPNP
668-6415
|
-
Meningococcal
vaccine study
to evaluate giving study vaccine with other routine immunizations in
children 4-6 years of age. The vaccine is licensed for use in
children 11 years and older
|
Laura Sass, MD |
Melody Skinner, RN,
MSN, CPNP
668-6415 |
-
Hepatitis A
vaccine study
for children
12
months of age
to evaluate
giving study vaccine with other routine immunizations.
|
Laura Sass, MD |
Mary
Beth Donner, RN, CCRC
668-6419 |
OTHER STUDIES
|
|
|
-
Lymphangioma
Treatment.
This study evaluates a drug to treat lymphangioma in children.
|
Craig Derkay, MD |
Lorrie Coggsdale, RN
668-8221 |
-
Blood
disorders.
Two studies are
testing an investigational oral medication to decrease iron stores
in the liver of children who have had repeated transfusions for
sickle cell anemia or other blood disorders. Enrolment is closed;
follow-up visits continue.
|
William Owen, MD |
Lorrie Coggsdale, RN
668-8221 |
-
Study for
children 1-5 yr of age with
GERD
|
Marc Tsou, MD |
Rebecca Sheeran, RN,
MSN, CPNP
668-9563 |
-
Study for
children 1-11 months of age with
GERD
|
Marc Tsou, MD |
Rebecca Sheeran, RN,
MSN, CPNP
668-9563 |
-
Migraine study-Device
study in patients 18 years of age and older with migraines and
patent foramen ovale (PFO)
|
Don Lewis, MD |
Rebecca Sheeran, RN,
MSN, CPNP
668-9563 |
-
Eosinophilic
esophagitis –
study to
evaluate medication in treatment of eosinophilic esophagitis in
children 2 to 17 years of age
|
Gregory Kobak, MD |
Lorrie Coggsdale, RN
668-8221 |
-
High blood
pressure
– study to
evaluate medication to treat high blood pressure in children 6-16
years of age
|
Reem Raafat, MD |
Mary
Beth Donner, RN, CCRC
668-6419 |
|
|
STAFF
-
Lorrie Coggsdale, RN, Clinical Research Coordinator
-
Mary Beth Donner, RN, CCRC, Certified Clinical Research
Coordinator
-
Rita Harvey, Administrative Assistant
-
Teresa Hedrick, BS, MT, CCRC, Laboratory Operations Supervisor,
Contract and Accounts Manager, Certified Clinical Research Coordinator
-
Rebecca Sheeran, RN, MSN,
CPNP Clinical Research Coordinator
-
Melody Skinner, RN, MSN, CPNP,
Clinical Research Coordinator
|
| |
|